Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 37.89% | 2.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 40.12% | 16.93% | |||
| Operating Income | -40.12% | -16.93% | |||
| Income Before Tax | -48.05% | -19.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -48.05% | -19.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.05% | -19.04% | |||
| EBIT | -40.12% | -16.93% | |||
| EBITDA | -40.12% | -16.89% | |||
| EPS Basic | -47.76% | -13.47% | |||
| Normalized Basic EPS | -47.77% | -13.46% | |||
| EPS Diluted | -47.76% | -13.47% | |||
| Normalized Diluted EPS | -47.77% | -13.46% | |||
| Average Basic Shares Outstanding | 0.18% | 4.91% | |||
| Average Diluted Shares Outstanding | 0.18% | 4.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||